Morl Christopher John

CIK 00017168211 companyWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001716821

Recent Transactions

38 trades

Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-16−3,011→ 150,344 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-16$3.95/sh+3,011→ 3,011 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-16$65.40/sh−3,011→ 0 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-15$65.23/sh−12,023→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-15−12,023→ 153,355 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-15$3.95/sh+12,023→ 12,023 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-08$60.12/sh−12,281→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-08−12,281→ 165,378 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-08$3.95/sh+12,281→ 12,281 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-07−1,650→ 177,659 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-07$3.95/sh+1,650→ 1,650 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-07$60.02/sh−1,650→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$3.95/sh+16,137→ 16,137 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$60.58/sh−800→ 1,200 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$58.38/sh−3,529→ 4,103 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$59.48/sh−2,103→ 2,000 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$61.58/sh−800→ 400 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$62.25/sh−400→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-01-02−16,137→ 179,309 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2020-01-02$57.74/sh−8,505→ 7,632 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-12+15,034→ 195,446 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-12$3.95/sh+15,034→ 15,034 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-12$60.00/sh−15,034→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$3.95/sh+11,647→ 11,647 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-10$55.00/sh−11,647→ 0 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-10+11,647→ 210,480 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-09$3.95/sh+3,387→ 3,387 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-09$55.00/sh−3,387→ 0 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-09+3,387→ 222,127 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-03+15,034→ 15,034 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2019-12-03+15,034→ 225,514 total
Sale
Deciphera Pharmaceuticals, Inc.
Common Stock
2019-12-03$50.00/sh−15,034→ 0 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-02-16+60,000→ 60,000 total
Award
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2018-01-30+52,000→ 52,000 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+20,283→ 20,283 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02+240,548→ 240,548 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−3,590→ 0 total
Exercise/Conversion
Deciphera Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2017-10-02−42,575→ 0 total

Companies

Deciphera Pharmaceuticals, Inc.
Chief Business Officer

Recent Filings

Address

C/O DECIPHERA PHARMACEUTICALS, INC. 500 TOTTEN POND ROAD

WALTHAM, MA, 02451

View on SEC.gov